InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the detailed record of transactions filed by Verstreken Jan, Chairman & CEO. Director active across 1 companies, notably HOLOGIC INC. Cumulatively, 9 reports have been published. Total volume traded: €486k. The latest transaction was disclosed on 17 May 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
€485,5656,500 shares@ €74.70240.0029% mcap61.8% of flow
Common Stock
SEC:0001127602-22-015147:0·
€130,1792,027 shares@ €64.22250.0008% mcap86.6% of flow
Common Stock
SEC:0001127602-21-029118·
€130,1792,027 shares@ €64.22250.0008% mcap16.6% of flow
Common Stock
SEC:0001127602-21-029118:0·
5,272 shares
Common Stock
SEC:0001127602-21-028823·
5,272 shares
Common Stock
SEC:0001127602-21-028823:0·
23,087 shares
Common Stock
SEC:0001127602-21-028283·
23,087 shares
Common Stock
SEC:0001127602-21-028283:0·
€20,145351 shares@ €57.39380.0001% mcap13.4% of flow
Common Stock
SEC:0001127602-21-021572·
€20,145351 shares@ €57.39380.0001% mcap2.6% of flow
Common Stock
SEC:0001127602-21-021572:0·
9 of 9 declarations
About Verstreken Jan
Verstreken Jan is the Group President, International at Hologic Inc. He oversees the company's international operations, focusing on innovation and product enhancement. Jan is recognized for his ability to lead diverse teams and develop effective strategies to meet global market needs.
